References
- 1
Bayliss W M, Starling E H.
The mechanism of pancreatic secretion.
J Physiol.
1902;
28
325-353
- 2
Edkins J S.
The chemical mechanism of gastric secretion.
J Physiol.
1906;
34
133-144
- 3
Zunz E, La Barre J.
Contributions à l'eŽtude des variations physiologiques de la secretion interne du
pancreas: relations entre les secretions externe et intene du pancreas.
Arch Int Physiol Biochim.
1929;
31
20-44
- 4
Creutzfeldt W.
The incretin concept today.
Diabetologia.
1979;
16
75-85
- 5
Holst J J, Ørskov C.
Incretin hormones - an update.
Scand J Clin Lab Invest.
2001;
234 (1)
75-85
- 6
Moore B, Edie E S, Abram J H.
On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane.
Biochem J.
1906;
1
28-38
- 7
Ahrén B, Holst J J, Efendic S.
Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes.
J Clin Endocrinol Metab.
2000;
85
1043-1048
- 8
Gutniak M, Ørskov C, Holst J, Ahrén B, Efendic S.
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects
and patients with diabetes mellitus.
N Engl J Med.
1992;
326
1316-1322
- 9
Nathan D M, Schreiber E, Fogel H, Mojsov S, Habener J F.
Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic
subjects.
Diabetes Care.
1992;
15
270-276
- 10
McIntyre N, Holdsworth C D, Turner D S.
New interpretation of oral glucose tolerance.
Lancet.
1964;
2
20-21
- 11
Yamada Y, Seino Y.
Physiology of GIP - lessons from GIP receptor KO mice.
Horm Metab Res.
2004;
36
771-774
- 12
Stoffers D A.
The development of ß cell mass: recent progress and potential role of GLP-1.
Horm Metab Res.
2004;
36
811-821
B. Ahrén
Department of Medicine, Biomedical Centre (BMC), Floor B11, Lund University
Sölvegatan 19 · 221 84 Lund · Sweden
Phone: +46 (46) 222 0758
Fax: +46 (46) 222 0757
Email: Bo.Ahren@med.lu.se
